Table 6.

Cancer risk calculated from the mean chronic dietary exposure to ‘aflatoxin total’^a, the upper bound potency estimate of the cancer risk and a prevalence of HBsAg of 5.61%

Age classb	Scenario	N	Cancer risk (aflatoxin‐induced cancers per year and per 100,000 subjects)
			Minimum		Median		Maximum
			LB	UB	LB	UB	LB	UB
Infants	Current ML	2	0.003	0.004	0.012	0.016	0.021	0.028
	Increased ML	2	0.006	0.007	0.021	0.025	0.037	0.043
Toddlers	Current ML	5	0.030	0.040	0.054	0.073	0.099	0.129
	Increased ML	5	0.053	0.062	0.095	0.114	0.173	0.202
Other children	Current ML	16	0.023	0.032	0.063	0.083	0.131	0.176
	Increased ML	16	0.041	0.049	0.110	0.130	0.230	0.275
Adolescents	Current ML	14	0.010	0.014	0.040	0.053	0.160	0.213
	Increased ML	14	0.018	0.022	0.070	0.083	0.281	0.333
Adults	Current ML	17	0.012	0.017	0.039	0.052	0.097	0.131
	Increased ML	17	0.022	0.026	0.068	0.081	0.171	0.204
Elderly	Current ML	12	0.006	0.008	0.027	0.035	0.057	0.077
	Increased ML	12	0.010	0.012	0.046	0.055	0.100	0.120
Very elderly	Current ML	4	0.017	0.022	0.028	0.037	0.057	0.076
	Increased ML	4	0.029	0.034	0.048	0.057	0.099	0.118

LB: lower bound; ML: maximum level; N: number of surveys; UB: upper bound.

^aMean chronic dietary exposure to ‘aflatoxin total’ from peanuts, peanut butter and processed products thereof (consumers only) calculated from mean LB and UB occurrence values for two different scenarios.

^bSection 2.4 describes the age range within each age class.